Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "S01XA" (52)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Retinol (S01XA02) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Vitamin A Blache
5 g
3.85
13.40
10 %
Ophtalmic ointment: Retinoli Palmitas 15000 UI
Bausch & Lomb Swiss AG
B / SL
FB
G
IP
CI
Vitamin A 10'000 E/g
Dispersa
4 g
PR
9.30
k.A.
Ophtalmic ointment: Retinoli Acetas 10000 UI
Novartis Ophthalmics AG
B
FB
G
Sodium Chloride, Hypertonic (S01XA03) 1 products
WHO-DDD
DrugBank.ca
IP
CI
NaCl 5 % Dispersa
10 ml
PR
PR
k.A.
Eye drops: Natrii Chloridum 50 mg/ml
OmniVision AG
B
FB
G
Ciclosporin (S01XA18) 3 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Ikervis, 1 mg/ml collyre en
émulsion (unidoses)
30 x 0.3 ml
PR
PR
k.A.
Santen SA
B
FB
G
IP
CI
PP
Ikervis, 1 mg/ml collyre en
émulsion (unidoses)
90 x 0.3 ml
PR
PR
k.A.
Santen SA
B
FB
G
IP
CI
Verkazia
120 x 0.3 ml
PR
PR
k.A.
Augentropfen Emulsion: Ciclosporinum 1 mg/ml
Santen SA
B
FB
G
Artificial Tears and Other Indifferent Preparations (S01XA20) 38 products
WHO-DDD
DrugBank.ca
IP
CI
Lacrycon
4 x 5 unidose(s)
8.73
18.55
10 %
Ophtalmic gel: Acidum Hyaluronicum
THEA Pharma S.A.
B / SL / SO
FB
G
IP
CI
Lacri-Vision
20 x 0.65 ml
5.50
15.20
10 %
Ophtalmic gel: Natrii Hyaluronas
OmniVision AG
B / SL / SG
FB
G
IP
CI
Lacri-Vision
60 x 0.65 ml
15.68
33.45
10 %
Ophtalmic gel: Natrii Hyaluronas
OmniVision AG
B / SL / SG
FB
G
IP
CI
Lacri-Vision
90 x 0.65 ml
23.51
42.00
10 %
Ophtalmic gel: Natrii Hyaluronas
OmniVision AG
B / SL / SG
FB
G
IP
CI
Lacrinorm
10 g
3.21
5.95
10 %
Ophtalmic gel: Carbomerum 980 2 mg
Bausch & Lomb Swiss AG
D / SL
FB
G
IP
CI
Liposic
10 g
2.86
5.30
10 %
Ophtalmic gel: Carbomerum 980 2 mg
Bausch & Lomb Swiss AG
D / SL
FB
G
IP
CI
Liposic Fluid UD
30 x 0.6 g
6.66
12.30
10 %
Ophtalmic gel: Carbomerum 980 2 mg
Bausch & Lomb Swiss AG
D / SL
FB
G
IP
CI
Siccafluid
Flasche(n) à 10 g
4.14
7.65
10 %
Ophtalmic gel: Carbomerum 974P 2.5 mg
THEA Pharma S.A.
D / SL
FB
G
IP
CI
Siccafluid UD 0.25 %
30 x 0.5 g
6.58
12.15
10 %
Ophtalmic gel: Carbomerum 974P 2.5 mg
THEA Pharma S.A.
D / SL
FB
G
IP
CI
Viscotears
10 g
3.43
6.35
10 %
Ophtalmic gel: Carbomerum 980 2 mg
Bausch & Lomb Swiss AG
D / SL
FB
G
IP
CI
Viscotears
3 x 10 g
9.76
18.00
10 %
Ophtalmic gel: Carbomerum 980 2 mg
Bausch & Lomb Swiss AG
D / SL
FB
G
IP
CI
Viscotears SDU
30 x 0.6 g
7.03
13.00
10 %
Ophtalmic gel (monodoses): Carbomerum 980 2 mg
Bausch & Lomb Swiss AG
● 
D / SL
FB
G
IP
CI
Cellufluid
10 ml
3.32
6.15
10 %
Eye drops: Carmellosum Natricum 5 mg/ml
AbbVie AG
D / SL
FB
G
IP
CI
Celluvisc
30 1 unidose(s) à 0.4 ml
4.96
9.15
10 %
Eye drops: Carmellosum Natricum 10 mg/ml
AbbVie AG
● 
D / SL
FB
G
IP
CI
Celluvisc
90 1 unidose(s) à 0.4 ml
12.54
23.15
10 %
Eye drops: Carmellosum Natricum 10 mg/ml
AbbVie AG
● 
D / SL
FB
G
IP
CI
Fluidose
30 1 unidose(s) à 0.4 ml
8.35
15.40
10 %
Eye drops: Carbomerum 980 1.3 mg/g
Cheplapharm Schweiz
GmbH
D / SL
FB
G
IP
CI
Lacrifluid
10 ml
2.73
5.05
10 %
Eye drops: Carbomerum 980 1.3 mg/g
Cheplapharm Schweiz
GmbH
D / SL
FB
G
IP
CI
Lacrinorm F UD
30 1 unidose(s) à 0.6 ml
6.85
12.65
10 %
Eye drops: Carbomerum 980 2 mg/ml
Bausch & Lomb Swiss AG
D / SL
FB
G
IP
CI
Lacrinorm F UD
60 1 unidose(s) à 0.6 ml
11.66
21.55
10 %
Eye drops: Carbomerum 980 2 mg/ml
Bausch & Lomb Swiss AG
D / SL
FB
G
IP
CI
Oculac
10 ml
2.32
4.30
10 %
Eye drops: Povidonum k 25 50 mg/ml
Alcon Switzerland SA
D / SL
FB
G
IP
CI
Oculac
3 x 10 ml
5.93
10.95
10 %
Eye drops: Povidonum k 25 50 mg/ml
Alcon Switzerland SA
D / SL
FB
G
IP
CI
Oculac SDU
20 1 unidose(s) à 0.4 ml
4.15
7.65
10 %
Eye drops: Povidonum k 25 50 mg
Alcon Switzerland SA
● 
D / SL
FB
G
IP
CI
Oculac SDU
60 1 unidose(s) à 0.4 ml
10.48
19.35
10 %
Eye drops: Povidonum k 25 50 mg
Alcon Switzerland SA
D / SL
FB
G
IP
CI
PP
Optava Unit Dose
30 1 unidose(s) à 0.4 ml
9.19
16.95
10 %
Eye drops: Carmellosum Natricum 5 mg/ml
AbbVie AG
● 
D / SL
FB
G
IP
CI
Protagent
10 ml
3.14
5.80
10 %
Eye drops: Povidonum k 25 20 mg/ml
Alcon Switzerland SA
D / SL
FB
G
IP
CI
Protagent SE
20 x 0.4 ml
5.72
10.55
10 %
Eye drops: Povidonum k 25 20 mg/ml
Alcon Switzerland SA
D / SL
FB
G
IP
CI
Protagent SE
80 x 0.4 ml
19.23
35.50
10 %
Eye drops: Povidonum k 25 20 mg/ml
Alcon Switzerland SA
D / SL
FB
G
IP
CI
Siccaprotect
10 ml
2.04
3.75
10 %
Eye drops: 2 Active Agents
URSAPHARM Schweiz
GmbH
D / SL
FB
G
IP
CI
Lacrycon
12 x 5
PR
PR
k.A.
Ophtalmic gel: Acidum Hyaluronicum
THEA Pharma S.A.
B
FB
G
IP
CI
Lacrycon
18 x 5
PR
PR
k.A.
Ophtalmic gel: Acidum Hyaluronicum
THEA Pharma S.A.
B
FB
G
IP
CI
Lacryvisc
10 g
3.26
6.00
k.A.
Ophtalmic gel: Carbomerum 974P 3 mg
Alcon Switzerland SA
D
FB
G
IP
CI
Lacryvisc SE
20 1 unidose(s) à 0.5 g
5.44
10.05
k.A.
Ophtalmic gel: Carbomerum 974P 3 mg
Alcon Switzerland SA
D
FB
G
IP
CI
Lacryvisc SE
50 1 unidose(s) à 0.5 g
12.15
22.40
k.A.
Ophtalmic gel: Carbomerum 974P 3 mg
Alcon Switzerland SA
D
FB
G
IP
CI
Liposic
3 x 10 g
9.77
18.05
k.A.
Ophtalmic gel: Carbomerum 980 2 mg
Bausch & Lomb Swiss AG
D
FB
G
IP
CI
Liposic Fluid UD
10 x 0.6 g
PR
PR
k.A.
Ophtalmic gel: Carbomerum 980 2 mg
Bausch & Lomb Swiss AG
D
FB
G
IP
CI
Liposic Fluid UD
60 x 0.6 g
14.49
26.70
k.A.
Ophtalmic gel: Carbomerum 980 2 mg
Bausch & Lomb Swiss AG
D
FB
G
IP
CI
Fluidose
10 1 unidose(s) à 0.4 ml
PR
PR
k.A.
Eye drops: Carbomerum 980 1.3 mg/g
Cheplapharm Schweiz
GmbH
D
FB
G
IP
CI
Tears Naturale
10 ml
PR
9.50
k.A.
Eye drops: 2 Active Agents
Alcon Switzerland SA
D / LPPV
FB
G
Mercaptamine (S01XA21) 1 products
WHO-DDD
IP
CI
Cystadrops 3.8 mg/ml
5 ml
PR
PR
k.A.
Eye drops: Mercaptaminum 3.8 mg/ml
Recordati AG
B
FB
G
Cenegermin (S01XA24) 1 products
WHO-DDD
IP
CI
Oxervate
7
PR
PR
k.A.
Eye drops: Cenegerminum
Dompé International SA
B
FB
G
Lifitegrast (S01XA25) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Xiidra
60 x 0.2 ml
PR
PR
k.A.
Eye drops: Lifitegrastum 50 mg/ml
Bausch & Lomb Swiss AG
B
FB
G
Voretigene Neparvovec (S01XA27) 1 products
WHO-DDD
L
IP
CI
Luxturna 5 x 10e12
319054.57
327657.80
10 %
Konzentrat und Lösungsmittel zur Herstellung einer Injektionslösung: Voretigenum Neparvovecum 5
Novartis Pharma
Schweiz AG
A / SL
FB
G
Sonstige Ophthalmologika (Diverse) (S01XA99) 4 products
WHO-DDD
DrugBank.ca
CI
A
Visiodoron Euphrasia
comp.
5 g
PR
PR
k.A.
Weleda AG
D
FB
G
A
Wala Euphrasia
Einzeldosis-Augentropfen
15 1 unidose(s) à 0.5 ml
PR
PR
k.A.
Eye drops: 2 Active Agents
WALA Schweiz AG
D
FB
G
CI
A
Visiodoron Euphrasia
Monodosen
20 x 0.4 ml
PR
PR
k.A.
Eye drops (monodoses): Euphrasia Officinalis D3 397.34mg / 0.4ml
Weleda AG
D
FB
G
CI
A
Visiodoron Euphrasia
10 ml
PR
PR
k.A.
anthroposophisches Arzneimittel: Euphrasia Officinalis D3 985.9 mg/g
Weleda AG
D
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home